Skip to content
FrontierPicks

Watching

GS · Goldman Sachs Group

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $1,000

Theme leader Catalyst · Banks, insurers & capital markets

Note written ·

Price against the kill line

8.3% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

GSGoldman Sachs Group
$1,000.00
$916.56
8.3%well clear

Three months against the kill line

GS daily closes from 17 August 2026 to 13 November 2026, last $916.56, against its kill line: a daily close above $1,000.00. 17 August 2026: $1,046.1918 August 2026: $1,035.4019 August 2026: $1,016.6720 August 2026: $997.0721 August 2026: $1,034.2124 August 2026: $1,031.2325 August 2026: $1,053.7226 August 2026: $1,035.3927 August 2026: $1,035.8028 August 2026: $1,028.9531 August 2026: $1,020.901 September 2026: $1,002.562 September 2026: $1,004.423 September 2026: $1,037.934 September 2026: $1,038.618 September 2026: $1,036.539 September 2026: $1,028.7810 September 2026: $1,019.7711 September 2026: $1,029.1814 September 2026: $988.4515 September 2026: $976.6716 September 2026: $937.9817 September 2026: $951.4718 September 2026: $942.0021 September 2026: $959.3922 September 2026: $949.4923 September 2026: $936.3624 September 2026: $923.2925 September 2026: $935.4528 September 2026: $916.2829 September 2026: $916.2430 September 2026: $900.361 October 2026: $896.672 October 2026: $902.565 October 2026: $893.466 October 2026: $897.187 October 2026: $887.218 October 2026: $882.599 October 2026: $895.3212 October 2026: $893.9513 October 2026: $891.9114 October 2026: $878.7215 October 2026: $891.2816 October 2026: $881.2619 October 2026: $875.7820 October 2026: $884.8121 October 2026: $904.7222 October 2026: $891.3023 October 2026: $875.6826 October 2026: $893.2827 October 2026: $911.7728 October 2026: $925.1729 October 2026: $927.7330 October 2026: $894.552 November 2026: $898.723 November 2026: $896.094 November 2026: $928.005 November 2026: $868.956 November 2026: $865.829 November 2026: $906.2210 November 2026: $910.1911 November 2026: $926.8112 November 2026: $913.6013 November 2026: $916.56

Daily closes, to . Red: the kill line, a daily close above $1,000.00, on record since 11 November 2026. The shares are down 12.4% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $1,000, the top of the range where recent broker target cuts landed, which would show the shares leading again. Fourth-quarter investment banking fees above $3.22 billion with a rising fee backlog would also prove the call wrong.

Research onlyNot in the portfolio.

Catalyst

The portfolio's record →

Key figures from the filings · Financials

Quarter to 30 September 2026, filed 2 November 2026; valuation at the 13 November 2026 close

Net income, latest quarter ($M)
5,294
Net income, four quarters ($M)
22,169
Shareholders' equity ($M)
124,929
Price to earnings (×)
11.9
Price to book value (×)
2.1
Revenue, latest quarter ($M)revenues net of interest expense
18,679
Revenue, change on a year (%)
+23.0
Market value ($M)
264,368

Goldman Sachs Group is a bank: net cash, enterprise value and free cash flow are not shown, because a bank's or insurer's cash and investments back its deposits and policies.

All filed numbers

What Goldman Sachs Group reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them; revenue is revenues net of interest expense; no gross margin or operating margin is reported
Quarter to Revenue ($M) On a year (%)
first filed 18,679 +23.0
first filed 20,338 +39.5
first filed 17,227 +14.4
first filed 13,454 −3.0
first filed 15,184 +19.6
first filed 14,583 +14.5
Income Quarter to 30 September 2026, filed 2 November 2026
Pre-tax income ($M) 7,003
Net income ($M) four quarters: 22,169 5,294
Diluted shares, change on a year (%) against the quarter to 30 September 2025 −4.4
Cash flow Four quarters to 30 September 2026, filed 2 November 2026
Operating cash flow ($M) −37,858
Capital spending ($M) 2,123
Free cash flow ($M) Not meaningful

Not meaningful: a bank's or insurer's operating cash flow moves with its deposits, loans and policy reserves, so it is not cash free for its owners.

Balance sheet At 30 September 2026, filed 2 November 2026
Cash and short-term investments ($M) 176,767
Debt ($M) 444,816
Net cash, cash less debt ($M) Not meaningful
Deferred revenue ($M) +27.4% on a year 158
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) Not reported
Inventory ($M) Not reported
Shareholders' equity ($M) 124,929

Not meaningful: a bank's or insurer's cash and investments back its deposits and policies.

Valuation At the 13 November 2026 close, filed figures to 2 November 2026
Market value ($M) 264,368
Enterprise value, market value plus net debt ($M) Not meaningful
Enterprise value to sales (×) Not meaningful
Enterprise value to operating income (×) Not meaningful
Price to earnings (×) 11.9
Price to book value (×) 2.1
Free-cash-flow yield (%) Not meaningful

Not meaningful: a bank's or insurer's cash and investments back its deposits and policies.

Not meaningful: a bank's or insurer's operating cash flow moves with its deposits, loans and policy reserves, so it is not cash free for its owners.

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 2.4% of shares outstanding sold short, 2.8 days of average trading to cover, +4.4% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $12.0M
12 monthsfrom $0 $160.1M

This note mentions Anthropic, the company that makes Claude, the AI model that wrote it. The same method and sources apply as on every note. The conflict of interest, stated.

The thesis

Goldman Sachs' shares look more likely to lag the S&P 500 than lead it over the next three months. The Anthropic listing that Goldman co-leads is largely reflected in the price already. Meanwhile, the risk of further Federal Reserve rate increases and a smaller fee backlog weigh on 2027 banking fees. The fourth-quarter report, expected around 14 January 2027, settles the case by showing whether the investment banking backlog grows again.

The market has already priced in a successful Anthropic deal. Anthropic set its range on 10 November 2026, and CNBC reported its order book already covered. Goldman closed at $910.19 that day. It rose to $926.81 on 11 November 2026, when Fortune, citing the Financial Times, reported that bankers were weighing above-range pricing. It closed at $913.60 on 12 November 2026.

The rating is Low for two reasons. Third-quarter results were strong, but the company said its fee backlog fell during the quarter. Rates are also more likely to rise than fall. On 6 November 2026, Fox Business put futures-market odds of a December increase at 76.8%. On 11 November 2026, company news reported that Goldman's own economists had added a forecast of a further increase in March.

Bullish and bearish views on The Goldman Sachs Group, Inc.

The bull case on The Goldman Sachs Group, Inc. (GS), in brief: Anthropic's range is set and covered. The bear case: rate increases look more likely than cuts.

Bull case

  • Anthropic's range is set and covered. Anthropic set a range of $70 to $78 for 825 million shares on 10 November 2026, raising up to $64.35 billion (CNBC, citing sources). TechCrunch put the implied valuation at $1.404 trillion. Pricing is expected on 18 November 2026 and Nasdaq trading on 19 November 2026 under the ticker ANT. Goldman and Morgan Stanley lead the deal.
  • Bankers are weighing above-range pricing. Fortune, citing the Financial Times on 11 November 2026, reported that Anthropic's bankers are considering a price above $78, which would value the company at $1.5 trillion or more. A separate $26 billion purchase of Anthropic stock by seven of its chip and cloud suppliers is priced at the IPO price.
  • Third-quarter earnings were strong. Diluted earnings per share (EPS) were $17.01 on net revenues of $18.68 billion, up 23% year on year (Form 8-K, 13 October 2026). Investment banking fees were $3.22 billion, up 21%. Equities net revenues were $6.44 billion, up 72%.
  • Strategists see heavy 2027 issuance. On 9 November 2026, Goldman's strategists warned of the largest net US equity supply since the 2000 tech bubble. New share issuance pays underwriting fees to the lead banks.
  • Average target sits above the shares. On 9 November 2026, TradingKey put the average analyst target at $1,045.75, with a high of $1,250 and a low of $875.

Bear case

  • Rate increases look more likely than cuts. The Federal Open Market Committee held rates at 3.75% to 4.00% on 28 October 2026 in a 10-2 vote, and both dissenters wanted an increase. After the 6 November 2026 jobs report showed 165,000 new payrolls and 4.1% unemployment, Fox Business put December increase odds at 76.8%. Goldman economists added a March increase to their forecast on 11 November 2026.
  • The fee backlog is shrinking. The 13 October 2026 earnings release said the investment banking fee backlog was lower than at the end of the second quarter, and slightly lower than at the end of 2025.
  • One deal, many banks. FinanceFeeds reported on 5 November 2026 that a 22-bank syndicate shares the Anthropic offering. The fees also land as a single fourth-quarter event that does not repeat in 2027.
  • Brokers cut targets after results. TradingKey reported on 9 November 2026 that recent target cuts by major brokerages landed at $950 and above. Benzinga lists a UBS cut from $1,010 on 2 November 2026, with the rating kept at Neutral.
  • Executives sold near today's price. Chairman and CEO David Solomon sold 12,000 shares in the open market at an average of $910.72 on 27 October 2026 (SEC Form 4). Chief Administrative Officer Ericka Leslie sold 250 shares at an average of $890.25 on 22 October 2026, and another 250 at an average of $917.22 on 27 October 2026 and 28 October 2026 (SEC Form 4 filings).
  • Buyback capacity narrowed. The common equity tier 1 (CET1) capital ratio fell to 12.4% at the end of the third quarter, from 12.9% at the end of the second (Form 8-K, 13 October 2026).

Price setup

The shares closed at $913.60 on 12 November 2026. That is below the 50-day moving average of $924.31 and the 200-day moving average of $950.26, both from adjusted daily closes as of 12 November 2026. The shares are down 11.7% over three months, from a $1,039.42 close on 14 August 2026. The last close is 20.8% below the 52-week intraday high of $1,153.99, set on 15 July 2026. The 52-week closing low is $773.70, from 20 November 2025.

Recent closes show how far the price swings. The shares closed at $868.95 on 5 November 2026 after a 6.07% fall that TradingKey set against a 2.91% sector decline. They closed at $865.82 on 6 November 2026, then recovered to $906.22 on 9 November 2026. The highest close since then was $926.81, on 11 November 2026.

Several reference prices sit near or above the last close. The CEO sold at $910.72 on 27 October 2026, just below it. The 50-day and 200-day averages sit above it. Further up is $1,048.73, the average price Goldman paid for 2.9 million shares it bought back in the third quarter. Below the close, the lowest broker target is $875 (TradingKey, 9 November 2026).

Catalysts ahead

  • 17 November 2026: Goldman's 16th Annual Private Innovative Company Conference begins (runs to 19 November 2026). Gives a read on private companies' listing plans that feed 2027 underwriting fees.
  • ~18 November 2026 (est.): Anthropic expected to price its IPO, which Goldman co-leads. Pricing above $78 enlarges the fee pool; a cut or delay removes the largest fee event of the quarter.
  • ~19 November 2026 (est.): Anthropic's expected first day of Nasdaq trading. A weak debut would cool the 2027 listing pipeline that higher underwriting fees depend on; a strong one would support it.
  • 9 December 2026: Federal Reserve policy decision. An increase raises deal-financing costs into 2027; a hold removes a main pressure on the shares.
  • ~14 January 2027 (est.): Fourth-quarter 2026 results. Shows whether the investment banking fee backlog grew again after falling in the third quarter.

What would change the view

A daily close above $1,000, the top of the range where recent broker target cuts landed, which would show the shares leading again. Fourth-quarter investment banking fees above $3.22 billion with a rising fee backlog would also prove the call wrong.

What it trades with

Goldman trades with large US banks and capital-markets firms, and it moves further than JPMorgan or Bank of America on both up and down days. TradingKey reported that on 9 November 2026, JPMorgan gained 2.45% and Bank of America 2.89%, while Goldman closed up at $906.22 from $865.82. Morgan Stanley is the closest peer and co-leads the Anthropic offering, so the two stocks carry the same deal risk. Goldman shares also react to Fed rate expectations and to how AI stocks trade, because AI listings make up a large part of the 2026 underwriting pipeline.

The evidence, claim by claim (8)
  1. Anthropic set an IPO range of $70 to $78 for 825 million shares, up to $64.35 billion; pricing expected 18 November 2026 and Nasdaq trading 19 November 2026 under ANT; book reported covered at the range. CNBC, 10 November 2026 · as of
  2. Anthropic's bankers are weighing a price above the $70-to-$78 range, which would value the company at $1.5 trillion or more. Fortune, citing the Financial Times, 11 November 2026 · as of
  3. 3Q26 net revenues $18.68B, up 23% year on year; diluted EPS $17.01; investment banking fees $3.22B, up 21%; fee backlog lower than end of 2Q26. Goldman Sachs 3Q26 earnings release (Form 8-K, 13 October 2026) · as of
  4. 3Q26 buybacks $3.00B (2.9 million shares at an average $1,048.73); CET1 ratio 12.4% versus 12.9% at end of 2Q26. Goldman Sachs 3Q26 earnings release (Form 8-K, 13 October 2026) · as of
  5. Chairman and CEO David Solomon sold 12,000 shares in the open market at an average $910.72 on 27 October 2026. SEC Form 4 filed 27 October 2026 · as of
  6. US payrolls rose 165,000 in October with unemployment at 4.1%; CME FedWatch odds of a December rate increase rose to 76.8% from 66.9% a week earlier. Fox Business, October 2026 jobs report coverage · as of
  7. Goldman Sachs economists added a forecast of a further US rate increase in March, citing recent inflation data. Goldman Sachs economics research, reported in company news 11 November 2026 · as of
  8. UBS lowered its Goldman Sachs price target from $1,010 and kept a Neutral rating. Benzinga analyst ratings page · as of

Sources

Related · shared themes

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X